Company Filing History:
Years Active: 2006-2013
Title: Rolf Burghaus: Innovator in Biomarker Development and Experiment Design
Introduction
Rolf Burghaus is a notable inventor based in Kaarst, Germany. He has made significant contributions to the fields of biomarker development and experimental design. With a total of 2 patents, Burghaus has demonstrated his expertise and innovative thinking in the medical and scientific communities.
Latest Patents
One of Burghaus's latest patents is a method for identifying predictive biomarkers from patient data. This invention relates to developing a biomarker for the prognosis of therapeutic treatment outcomes based on data obtained from clinical studies. The method involves subdividing data that remains unchanged by therapy into diagnostic and genomic parameters. The marker is defined by a combination of these parameters, with a focus on specifying the maximum number of parameters from the outset to manage system complexity. The search for defining parameters is conducted through the sequential combination of clinical and genomic parameters.
Another significant patent by Burghaus is a method and system for the automatic design of experiments. This invention outlines a systematic approach to designing experiments automatically, enhancing efficiency and accuracy in research settings.
Career Highlights
Throughout his career, Rolf Burghaus has worked with prominent companies, including Bayer Aktiengesellschaft and Bayer Technology Services GmbH. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical technology.
Collaborations
Burghaus has collaborated with notable colleagues, including Georg Mogk and Thomas Mrziglod. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation.
Conclusion
Rolf Burghaus is a distinguished inventor whose work in biomarker development and experimental design has made a significant impact in the scientific community. His innovative patents and collaborations reflect his commitment to advancing medical research and technology.